Skip to main content
Fig. 3 | Cancer Cell International

Fig. 3

From: SNHG29 regulates miR-223-3p/CTNND1 axis to promote glioblastoma progression via Wnt/β-catenin signaling pathway

Fig. 3

CTNND1 served as a target gene of miR-223-3p in glioblastoma. a The Venn diagram described the result of screening. b, c The expression of CTNND1 or FOXO1 was tested by RT-qPCR. d The detection of CTNND1 mRNA expression and catenin delta-1 protein expression was carried out in RT-qPCR and western blot assay. e Data from starBase indicated a negative correlation between miR-223-3p and CTNND1. f The examination of CTNND1 mRNA expression and catenin delta-1 protein expression was carried out in RT-qPCR and western blot assay. g The binding site of miR-223-3p on CTNND1 was predicted by starBase. h, i The interaction between miR-223-3p and CTNND1 was confirmed by RIP and luciferase reporter assays. **P < 0.01

Back to article page